FDA Drug Recalls

Recalls / Class III

Class IIID-1516-2019

Product

Methylergonovine Maleate USP 0.2 mg Tablets a) 12 count (NDC 69238-1605-02) and b) 28 count bottles (NDC 69238-1605-08)

Affected lot / code info
a) Lot # BA10619A, b) Lot # BA10619B, exp. date 07/2020

Why it was recalled

Presence of Foreign Tablet/Capsule; one Promethazine tablet was found in a bottle of Methylergonovine Maleate tablets

Recalling firm

Firm
Amneal Pharmaceuticals, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
50 Horseblock Rd, N/A, Brookhaven, New York 11719-9509

Distribution

Quantity
a) 2,256 bottles; b) 240 bottles
Distribution pattern
Product was distributed to three major distributors who may have further distributed the product nationwide.

Timeline

Recall initiated
2019-07-18
FDA classified
2019-07-24
Posted by FDA
2019-07-31
Terminated
2020-04-22
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1516-2019. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.